Contract facts
FederalNo full NAICS 622110 intel page yet. Browse NAICS intelligence
CLINICAL PHARMACIST EO14042 is a federal award for Fa4613 90 Cons Pk held by Frontline National, LLC. Estimated value $801K ($324K obligated). Current period of performance ends Dec 19, 2023. Last award drew 9 bidders. Place of performance: FE WARREN AFB WY.
Recompete timing
PublicCurrent PoP ended Dec 19, 2023 (976 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordFrontline National, LLC — $23.5M obligated across 40 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract FA461319FA010?
FA461319FA010 (Clinical pharmacist eo14042) is a Fa4613 90 Cons Pk award with a potential value of $801K, currently held by Frontline National, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded FA461319FA010?
Fa4613 90 Cons Pk awarded FA461319FA010 to Frontline National, LLC (potential $801K).
Who is the incumbent on FA461319FA010?
Frontline National, LLC is the incumbent with $23.5M across 40 related awards in SCOUT’s public footprint. The current period of performance ends Dec 19, 2023.
When does Frontline National, LLC’s FA461319FA010 come up for recompete?
SCOUT tracks a period-of-performance end of Dec 19, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
